CCI Clears BC Asia-IIFL, Viatris-Biocon Biologics Deals, Acquisition of GSK Restructuring
The Competition Commission of India (CCI) on Tuesday granted its approval to the acquisition of up to 24.98 per cent shareholding of IIFL Wealth Management Limited by BC Asia Investments X Ltd. It has also approved the proposed transaction…